Siloton secured £8.4 million from Innovate UK to accelerate development of its handheld GiraffeOCT retinal imaging system Clinical trials with Sunderland Specialist Eye Hospital will evaluate the ...
Zeiss Medical Technology announced the commercial availability of its CT Lucia 621P monofocal IOL in Japan, expanding the company's cataract surgery portfolio in the Japanese market. The CT Lucia 621P ...
The acquisition adds Encelto, the first FDA-approved treatment for adults with idiopathic MacTel type 2, to Alcon’s retina portfolio Alcon announced its acquisition of Neurotech Pharmaceuticals for ...
Significant benefits were reported in steroid-free quiescence, retinal vascular leakage, macular edema, and visual functioning No new safety signals were identified, and Priovant plans an FDA ...
RxSight appointed Taryn Conway as chief commercial officer and Frank Shields as executive vice president of sales and commercial strategy The appointments support efforts to expand customer engagement ...
Envision and VisionServe Alliance announced that their 2027 National Conference will take place May 11-14, 2027, at the Royal Sonesta Houston Galleria Hotel in Houston, Texas, bringing together ...
LUCIA did not achieve the primary endpoint of statistical noninferiority in mean change in BCVA versus on-label aflibercept (Eylea, Regeneron) control, despite demonstrating visual improvement. Key ...
SpyGlass Pharma announced positive 4-year first-in-human (FIH) trial results for the Bimatoprost Drug Pad-IOL (BIM-IOL) System in patients with mild-to-moderate open angle glaucoma or ocular ...
Opus Genetics announced that the FDA approved its supplemental new drug application for phentolamine ophthalmic solution 0.75% (Ryzumvi) for the treatment of presbyopia. Phentolamine ophthalmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results